Furthermore, we run a second suite of tests to compare the highest risk variants (\(j\) = 4) used in the first section against the true frequencies of SCZ and BPD in Canada.  We assume that these variants have a 100% certainty of causing a SCZ or BPD diagnosis if present in an individual’s genome. The age and sex distributions of SCZ and BPD classified by gnomAD are noted, constrained by ages <30, 50–55, and >80.  Fig. \ref{628883} demonstrates the age and sex brackets in Canada and those of gnomAD for BPD.